This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Unicycive Therapeutics faces class action
Business class action

Unicycive Therapeutics faces class action

Analysis based on 7 articles · First reported Sep 12, 2025 · Last updated Oct 10, 2025

Sentiment
-20
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The class action lawsuit against Unicycive Therapeutics is likely to negatively impact its stock price and investor confidence due to allegations of false and misleading statements. For Rosen Law Firm, this event could enhance its reputation as an investor rights law firm.

Pharmaceuticals Legal Services
Event Summary

Rosen Law Firm has filed a class action lawsuit against Unicycive Therapeutics on behalf of investors who purchased its securities between March 29, 2024, and June 27, 2025. The lawsuit alleges that Unicycive Therapeutics made false and misleading statements regarding its ability to meet the United States — Food and Drug Administration's manufacturing compliance requirements and the regulatory prospects of its oxylanthanum carbunate (OLC) New Drug Application. Investors are encouraged to join the class action by the October 14, 2025, lead plaintiff deadline.

Entities Involved
stock
Unicycive Therapeutics
Unicycive Therapeutics is the defendant in a class action lawsuit alleging false and misleading statements regarding its manufacturing compliance and regulatory prospects for oxylanthanum carbunate (OLC). This event negatively impacts Unicycive Therapeutics's reputation and stock price.
Importance 100.0 Sentiment -50.0
priv
Rosen Law Firm
Importance 0.0 Sentiment 0.0
per
Philip Kim
Importance 0.0 Sentiment 0.0
per
Lawrence Rosen
Importance 0.0 Sentiment 0.0
govactor
United States — Food and Drug Administration
Importance 0.0 Sentiment 0.0
Relationships
Unicycive Therapeutics related ↔ United States — Food and Drug Administration
Rosen Law Firm related ↔ Philip Kim
Rosen Law Firm related ↔ Lawrence Rosen
Rosen Law Firm related ↔ United States — Food and Drug Administration
Philip Kim attorney ↔ Lawrence Rosen Philip Kim is an attorney at the Rosen Law Firm, working under the direction of founding partner Lawrence Rosen. Kim fre
Philip Kim related ↔ United States — Food and Drug Administration
Lawrence Rosen related ↔ United States — Food and Drug Administration
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.